tiprankstipranks
Trending News
More News >
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
Advertisement

KYORIN Pharmaceutical Co.,Ltd. (4569) Income Statement

Compare
3 Followers

KYORIN Pharmaceutical Co.,Ltd. Income Statement

Last quarter (Q3 2024), KYORIN Pharmaceutical Co.,Ltd.'s total revenue was ¥34.15B, an increase of 5.62% from the same quarter last year. In Q3, KYORIN Pharmaceutical Co.,Ltd.'s net income was ¥1.18B. See KYORIN Pharmaceutical Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B¥ 102.90B
Gross Profit
¥ 59.51B¥ 51.41B¥ 50.17B¥ 49.44B¥ 51.63B
Operating Expenses
¥ 46.97B¥ 45.40B¥ 45.04B¥ 44.43B¥ 45.84B
Depreciation and Amortization
¥ 4.60B¥ 4.29B¥ 3.84B¥ 3.71B¥ 3.56B
EBITDA
¥ 17.55B¥ 11.37B¥ 8.96B¥ 8.72B¥ 9.34B
Operating Income
¥ 12.55B¥ 6.01B¥ 5.12B¥ 5.01B¥ 5.79B
Other Income/Expenses
¥ 223.00M¥ 1.01B¥ 1.78B¥ 209.00M¥ 2.57B
Pretax Income
¥ 12.77B¥ 7.02B¥ 6.91B¥ 5.22B¥ 8.35B
Net Income
¥ 9.09B¥ 5.32B¥ 4.72B¥ 3.93B¥ 6.13B
Per Share Metrics
Basic EPS
¥ 158.16¥ 92.73¥ 82.42¥ 68.62¥ 106.99
Diluted EPS
¥ 158.16¥ 92.73¥ 82.42¥ 68.62¥ 106.99
Weighted Average Shares Outstanding
57.45M 57.39M 57.30M 57.30M 57.30M
Weighted Average Shares Outstanding (Diluted)
57.45M 57.39M 57.30M 57.30M 57.30M
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis